Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
Authors:
- Yong Ping LinYLYong Ping Lin
- Zi Feng YangZYZi Feng Yang
- Ying LiangYLYing Liang
- Zheng Tu LiZLZheng Tu Li
- Helen S. BondHBHelen S. Bond
- Huiying ChuaHCHuiying Chua
- Ya Sha LuoYLYa Sha Luo
- Yuan ChenYCYuan Chen
- Ting Ting ChenTCTing Ting Chen
- Wen Da GuanWGWen Da Guan
- Jimmy Chun Cheong LaiJLJimmy Chun Cheong Lai
- Yu Lam SiuYSYu Lam Siu
Open Access
- 4 November 2016
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 16 (1) , 1-6
Abstract
Since the identification in early 2013 of severe disease caused by influenza A(H7N9) virus infection, there have been few attempts to characterize the full severity profile of human infections. Our objective was to estimate the number and severity of H7N9 infections in Guangzhou, using a serological study. We collected residual sera from patients of all ages admitted to a hospital in the city of Guangzhou in southern China in 2013 and 2014. We screened the sera using a haemagglutination inhibition assay against a pseudovirus containing the H7 and N9 of A/Anhui/1/2013(H7N9), and samples with a screening titer ≥10 were further tested by standard hemagglutination-inhibition and virus neutralization assays for influenza A(H7N9). We used a statistical model to interpret the information on antibody titers in the residual sera, assuming that the residual sera provided a representative picture of A(H7N9) infections in the general population, accounting for potential cross-reactions. We collected a total of 5360 residual sera from December 2013 to April 2014 and from October 2014 to December 2014, and found two specimens that tested positive for H7N9 antibody at haemagglutination inhibition titer ≥40 and a neutralization titer ≥40. Based on this, we estimated that 64,000 (95 % credibility interval: 7300, 190,000) human infections with influenza A(H7N9) virus occurred in Guangzhou in early 2014, with an infection-fatality risk of 3.6 deaths (95 % credibility interval: 0.47, 15) per 10,000 infections. Our study suggested that the number of influenza A(H7N9) virus infections in Guangzhou substantially exceeded the number of laboratory-confirmed cases there, albeit with considerable imprecision. Our study was limited by the small number of positive specimens identified, and larger serologic studies would be valuable. Our analytic framework would be useful if larger serologic studies are done.Keywords
Funding Information
- Research Grants Council, University Grants Committee (T11-705/14N)
- the Area of Excellence Scheme of the Hong Kong University Grants Committee (AoE/M-12/06)
- Health and Medical Research Fund (HK) (RRG-11)
- municipal science and technology bureau foundation of guangzhou (2014Y2-00031)
- Science research project of the Guangdong Province (2013B020224006 & 2016A050503047)
- the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (U54 GM088558)
This publication has 18 references indexed in Scilit:
- Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in ChinaNew England Journal of Medicine, 2014
- Characteristics of Vaccine Failures in a Randomized Placebo-controlled Trial of Inactivated Influenza Vaccine in ChildrenThe Pediatric Infectious Disease Journal, 2014
- Case Fatality Risk of Influenza A (H1N1pdm09)Epidemiology, 2013
- Avian-Origin Influenza A(H7N9) Infection in Influenza A(H7N9)–Affected Areas of China: A Serological StudyThe Journal of Infectious Diseases, 2013
- Monitoring Avian Influenza A(H7N9) Virus through National Influenza-like Illness Surveillance, ChinaEmerging Infectious Diseases, 2013
- Monitoring Avian Influenza A(H7N9) Virus through National Influenza-like Illness Surveillance, ChinaEmerging Infectious Diseases, 2013
- Human infection with avian influenza A H7N9 virus: an assessment of clinical severityThe Lancet, 2013
- Serologic Study for Influenza A (H7N9) among High-Risk Groups in ChinaNew England Journal of Medicine, 2013
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) VirusNew England Journal of Medicine, 2013
- Inference from Iterative Simulation Using Multiple SequencesStatistical Science, 1992